Cargando…

Reply to Dorgham et al., “Considering Personalized Interferon Beta Therapy for COVID-19”

Detalles Bibliográficos
Autores principales:	Davoudi-Monfared, Effat, Khalili, Hossein
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097451/ https://www.ncbi.nlm.nih.gov/pubmed/33558288 http://dx.doi.org/10.1128/AAC.00083-21

Ejemplares similares

Considering Personalized Interferon Beta Therapy for COVID-19
por: Dorgham, Karim, et al.
Publicado: (2021)

The threat of carbapenem-resistant gram-negative bacteria in a Middle East region
por: Davoudi-Monfared, Effat, et al.
Publicado: (2018)

In Reply to Özkıdık et al.
por: Bozkurt, Hasan, et al.
Publicado: (2018)

Reply to Sarridou et al.
por: Koster, Andreas, et al.
Publicado: (2021)

Reply to Romano et al.
por: Santhirakumaran, Gowthanan, et al.
Publicado: (2022)

In Reply to Qureshi et al
por: Hesse, Jennifer, et al.
Publicado: (2022)

Reply to Rakovich et al.
por: Dimitrovska, Natasha Toleska, et al.
Publicado: (2022)

Reply to Gasparovic et al.
por: Knol, Wiebe G, et al.
Publicado: (2022)

Reply to Royse et al.
por: Thuijs, Daniel J F M, et al.
Publicado: (2022)

In Reply to Sindhu et al.
por: Huang, Austin, et al.
Publicado: (2022)

In Reply to Li et al
por: Lachos-Dávila, Alberto, et al.
Publicado: (2022)

In Reply to Li et al.
por: Darzikolaee, Nima Mousavi, et al.
Publicado: (2023)

In Reply to Wada et al
por: Kil, Whoon Jong, et al.
Publicado: (2023)

Reply to Amacher et al.
por: Haidari, Zaki, et al.
Publicado: (2023)

In Reply to Bäcker et al.
por: Kato, Ryohei, et al.
Publicado: (2023)

HIV-Related Knowledge in PLHIV: Issues to Consider in the Indian Context—A Reply to Banagi Yathiraj et al
por: Basu, Saurav
Publicado: (2018)

Response to Morrell et al's reply
por: Miller, Anthony B
Publicado: (2017)

Reply to the comment by Osuka et al.
por: Endo, Akira, et al.
Publicado: (2020)

In reply Asif M et al.
por: Asif, Muhammad, et al.
Publicado: (2021)

Reply to K. Takada et al.
por: Ballman, Madison, et al.
Publicado: (2021)

Reply to R Kirwan et al.
por: Ludwig, David S, et al.
Publicado: (2022)

Reply to M Mialon et al.
por: Kraak, Vivica I.
Publicado: (2023)

Authors’ Reply to: VanderWeele et al., Chiolero, and Schooling et al.
por: Broadbent, Alex, et al.
Publicado: (2016)

Point-of-care ultrasound: reply to Andronikou et al. and Györgyi et al.
por: Arthurs, Owen J., et al.
Publicado: (2021)

Reply to Lombardi et al
por: Chen, Jun, et al.
Publicado: (2023)

Reply to Boodman et al
por: Ordaya, Eloy E, et al.
Publicado: (2023)

Reply to Collis et al.
por: Rauseo, Adriana M, et al.
Publicado: (2023)

Reply to the letter from Poljak et al
por: Walboomers, JMM, et al.
Publicado: (1996)

Reply to the letter from Vermeuler et al
por: Hewitt, RE
Publicado: (1996)

Reply to P-A Dugué et al.
por: Mandaviya, Pooja R, et al.
Publicado: (2020)

Reply to Letter to the Editor by Yin et al.
por: Coleman, Brenda L., et al.
Publicado: (2021)

Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”
por: Rizk, John G., et al.
Publicado: (2020)

A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19
por: Davoudi-Monfared, Effat, et al.
Publicado: (2020)

Reply to the letter from Dr. Miao et al.
por: Tanimura, Yuko, et al.
Publicado: (2016)

Reply to M Mindrum and J Moore et al
por: Ludwig, David S, et al.
Publicado: (2022)

Reply to Mathur et al.: Many-analyst studies should consider effect sizes and CIs
por: Breznau, Nate, et al.
Publicado: (2023)

Reply to the letter from B Stausbøl-Grøn et al
por: West, C
Publicado: (1998)

Reply to Offiah et al.: The triad of shaken baby syndrome
por: Axelsson, E. Susanna, et al.
Publicado: (2017)

Reply to the letter from Dr. Pirjo Pärnänen et al
por: Bose, Mukulika, et al.
Publicado: (2021)

Letter to the Editor Reply: Kleebayoon et al.
por: Meador, Catherine B., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jh39f1va4rgbuovns29sh294s3